Earnings Feed
Start Free
Home/Insiders/Levine James E.
LJ
SEC Insider//CIK 0001463151

Levine James E.

CIK 00014631513 companiesCAMBRIDGE, MA
SEC Profile

Transactions

50

Companies

3

Filings

13

CIK

0001463151

Recent Transactions

50 trades
  • Award
    Cardiff Oncology, Inc.$CRDF

    Stock Options

    2025-03-11+332,621→ 1,295,117 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2024-12-18$5.00/sh+2,400→ 67,716 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2024-12-17$5.42/sh+2,752→ 65,316 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2024-12-16$3.83/sh+2,564→ 62,564 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Stock Options

    2024-03-07+205,008→ 962,496 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Stock Options

    2023-03-15+197,472→ 757,488 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2022-09-16$1.56/sh+30,000→ 60,000 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Stock Options

    2022-03-09+170,016→ 560,016 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2021-09-10$6.75/sh+5,000→ 10,000 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2021-09-10$6.62/sh+5,000→ 5,000 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2021-09-10$6.38/sh+10,000→ 20,000 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2021-09-10$6.35/sh+5,000→ 25,000 total
  • Purchase
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2021-09-10$6.32/sh+5,000→ 30,000 total
  • Award
    Cardiff Oncology, Inc.$CRDF

    Common Stock

    2021-07-12+390,000→ 390,000 total
  • Award
    Cidara Therapeutics, Inc.$CDTX

    Employee Stock Option (right to buy)

    2021-03-17+130,000→ 130,000 total
  • Purchase
    Cidara Therapeutics, Inc.$CDTX

    Common Stock

    2020-11-10$2.01/sh+50,000→ 50,000 total
  • Exercise/Conversion
    Cidara Therapeutics, Inc.$CDTX

    Employee Stock Option (right to buy)

    2020-03-19+110,000→ 110,000 total
  • Award
    Cidara Therapeutics, Inc.$CDTX

    Common Stock

    2020-03-19+25,000→ 61,891 total
  • Exercise of In-Money
    Cidara Therapeutics, Inc.$CDTX

    Subscription Rights (right to buy)

    2020-01-28−6,891→ 0 total
  • Exercise of In-Money
    Cidara Therapeutics, Inc.$CDTX

    Common Stock

    2020-01-28$2.51/sh+6,891→ 211,891 total
  • Purchase
    Cidara Therapeutics, Inc.$CDTX

    Common Stock

    2019-09-24$1.91/sh+30,000→ 205,000 total
  • Purchase
    Cidara Therapeutics, Inc.$CDTX

    Common Stock

    2019-09-24$1.91/sh+30,000→ 30,000 total
  • Award
    Cidara Therapeutics, Inc.$CDTX

    Stock Option (right to buy)

    2018-12-03+175,000→ 175,000 total
  • Disposition to Issuer
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2013-10-31−20,000→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2013-10-31−24,063→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2013-10-31−13,125→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2013-10-31−10,937→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2013-10-31−129,695→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Common Stock

    2013-10-31$4.00/sh−109,166→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2013-10-31−84,556→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2013-10-31−34,796→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2013-10-31−444→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2013-10-31−16,875→ 0 total
  • Disposition to Issuer
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2013-10-31−20,833→ 0 total
  • Award
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2013-08-01+24,063→ 24,063 total
  • Award
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2013-08-01+10,937→ 10,937 total
  • Award
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2012-08-02$4.23/sh+16,875→ 16,875 total
  • Award
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2012-08-02$4.23/sh+13,125→ 13,125 total
  • Purchase
    VERENIUM CORP

    Common Stock

    2012-05-15$3.65/sh+4,994→ 109,166 total
  • Purchase
    VERENIUM CORP

    Common Stock

    2011-08-25$3.18/sh+25,000→ 104,172 total
  • Purchase
    VERENIUM CORP

    Common Stock

    2011-08-12$1.69/sh+25,000→ 79,172 total
  • Award
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2011-02-24+34,796→ 34,796 total
  • Award
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2011-02-24+129,695→ 129,695 total
  • Award
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2010-09-07+84,556→ 84,556 total
  • Award
    VERENIUM CORP

    Non-Qualified Stock Option (Right to Buy)

    2010-09-07+444→ 444 total
  • Purchase
    VERENIUM CORP

    Common Stock

    2010-08-16$2.51/sh+25,150→ 54,172 total
  • Purchase
    VERENIUM CORP

    Common Stock

    2010-08-13$2.50/sh+24,856→ 29,022 total
  • Award
    VERENIUM CORP

    Employee Stock Option (Right to Buy)

    2009-12-11$4.12/sh+20,000→ 20,000 total
  • Award
    VERENIUM CORP

    Stock Option (Right to Buy)

    2009-11-12+20,833→ 20,833 total
  • Disposition to Issuer
    VERENIUM CORP

    Stock Option (Right to Buy)

    2009-11-12−20,833→ 0 total

Companies

3

Recent Filings

13

Address

55 CAMBRIDGE PARKWAY

CAMBRIDGE, MA, 02142

View on SEC.gov